67 related articles for article (PubMed ID: 27707671)
1. Cytogenetics in the management of children and adult acute lymphoblastic leukemia (ALL): an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Baranger L; Cuccuini W; Lefebvre C; Luquet I; Perot C; Radford I; Lafage-Pochitaloff M
Ann Biol Clin (Paris); 2016 Oct; 74(5):547-560. PubMed ID: 27707671
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Tueur G; Quessada J; De Bie J; Cuccuini W; Toujani S; Lefebvre C; Luquet I; Michaux L; Lafage-Pochitaloff M
Curr Res Transl Med; 2023; 71(4):103434. PubMed ID: 38064905
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
De Bie J; Quessada J; Tueur G; Lefebvre C; Luquet I; Toujani S; Cuccuini W; Lafage-Pochitaloff M; Michaux L
Curr Res Transl Med; 2023; 71(4):103431. PubMed ID: 38016418
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Bidet A; Quessada J; Cuccuini W; Decamp M; Lafage-Pochitaloff M; Luquet I; Lefebvre C; Tueur G;
Curr Res Transl Med; 2023; 71(4):103421. PubMed ID: 38016419
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetics in the management of mature B-cell non-Hodgkin lymphomas: Guidelines from the Groupe Francophone de Cytogénétique Hematologique (GFCH).
Lefebvre C; Veronese L; Nadal N; Gaillard JB; Penther D; Daudignon A; Chauzeix J; Nguyen-Khac F; Chapiro E
Curr Res Transl Med; 2023; 71(4):103425. PubMed ID: 38016420
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics in the management of hematologic neoplasms with germline predisposition: guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gachard N; Lafage-Pochitaloff M; Quessada J; Auger N; Collonge-Rame MA
Curr Res Transl Med; 2023; 71(4):103416. PubMed ID: 37865978
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Nguyen-Khac F; Balogh Z; Chauzeix J; Veronese L; Chapiro E
Curr Res Transl Med; 2023; 71(4):103410. PubMed ID: 38039634
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gaillard JB; Chapiro E; Daudignon A; Nadal N; Penther D; Chauzeix J; Nguyen-Khac F; Veronese L; Lefebvre C
Curr Res Transl Med; 2023; 71(4):103428. PubMed ID: 38016421
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetics in the management of multiple Myeloma: The guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Daudignon A; Cuccuini W; Bracquemart C; Godon C; Quilichini B; Penther D
Curr Res Transl Med; 2023; 71(4):103427. PubMed ID: 38035476
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH).
Decamp M; Klein E; Godon C; Lestringant V; Roynard P; Theisen O; Jimenez-Pocquet M; Roche-Lestienne C; Bidet A; Veronese L
Curr Res Transl Med; 2023; 71(4):103424. PubMed ID: 38011761
[TBL] [Abstract][Full Text] [Related]
11. Response to the Comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors.
Siebert R; Schuh A; Ott G; Cree IA; Du MQ; Ferry J; Hochhaus A; Naresh KN; Solary E; Khoury JD
Leukemia; 2023 May; 37(5):1170-1172. PubMed ID: 36973349
[No Abstract] [Full Text] [Related]
12. Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: the Cancer and Leukemia Group B experience.
Mrózek K; Carroll AJ; Maharry K; Rao KW; Patil SR; Pettenati MJ; Watson MS; Arthur DC; Tantravahi R; Heerema NA; Koduru PR; Block AW; Qumsiyeh MB; Edwards CG; Sterling LJ; Holland KB; Bloomfield CD
Int J Oncol; 2008 Aug; 33(2):239-44. PubMed ID: 18636143
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetics in the management of hematological malignancies: Guidelines from the Groupe Francophone de Cytogénétique Hématologique.
Nguyen-Khac F; Bidet A; Chapiro E; Lefebvre C; Michaux L; Troadec MB
Curr Res Transl Med; 2023; 71(4):103411. PubMed ID: 37984195
[No Abstract] [Full Text] [Related]
14. Cytogenetics in the management of clonal chromosomal abnormalities of undetermined significance and persistent polyclonal B-cell lymphocytosis: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Nadal N; Auger N; Bidet A; Nguyen-Khac F
Curr Res Transl Med; 2023; 71(4):103426. PubMed ID: 38016423
[TBL] [Abstract][Full Text] [Related]
15. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH).
Rack KA; van den Berg E; Haferlach C; Beverloo HB; Costa D; Espinet B; Foot N; Jeffries S; Martin K; O'Connor S; Schoumans J; Talley P; Telford N; Stioui S; Zemanova Z; Hastings RJ
Leukemia; 2020 Aug; 34(8):2262-2264. PubMed ID: 32042082
[No Abstract] [Full Text] [Related]
16. Cytogenetics and genomics in pediatric acute lymphoblastic leukaemia.
Antić Ž; Lentes J; Bergmann AK
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101511. PubMed ID: 38092485
[TBL] [Abstract][Full Text] [Related]
17. Added value of molecular karyotype in childhood acute lymphoblastic leukemia.
Camuset M; Le Calvez B; Theisen O; Godon C; Grain A; Thomas C; Couec ML; Béné MC; Rialland F; Eveillard M
Cancer Innov; 2023 Dec; 2(6):513-523. PubMed ID: 38125768
[TBL] [Abstract][Full Text] [Related]
18. The t(X;20)(q13;q13) translocation is a good prognostic factor in myeloid neoplasms: A report of 25 cases from the Groupe Francophone de Cytogénétique Hématologique.
Nguyen-Khac F; Muller M; Chapiro E; Abermil N; Collonge-Rame MA; Daudignon A; Gaillard B; Guzun D; Ittel A; Lefebvre C; Lesesve JF; Mozziconacci MJ; Penther D; Quessada J; Settegrana C; Smagghe L; Terre C; Veronese L; Hirsch P; Troadec MB
Am J Hematol; 2024 Apr; ():. PubMed ID: 38613825
[No Abstract] [Full Text] [Related]
19. Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia.
Soler G; Ouedraogo ZG; Goumy C; Lebecque B; Aspas Requena G; Ravinet A; Kanold J; Véronèse L; Tchirkov A
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046792
[TBL] [Abstract][Full Text] [Related]
20. DNA index as prognostic factor in childhood acute lymphoblastic leukemia in the COG-TARGET database.
Qiu KY; Liao XY; He ZW; Wu RH; Li Y; Xu LH; Zhou DH; Fang JP
BMC Cancer; 2021 Jul; 21(1):813. PubMed ID: 34266412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
